Effects of antifibrotic substances on pancreatic fibrosis following acute necrotizing pancreatitis.
This study was designed to search for a way to inhibit pancreatic fibrosis following acute pancreatitis. Experimental necrotizing pancreatitis was induced by a freezing procedure in the pancreas of male Wistar rats. After the freezing procedure, the rats were divided into 3 groups: nothing addition was done to the control group, while the other 2 groups received daily intraperitoneal administration of antifibrotic substances (colchicine or L-azetidine-2-carboxylic acid (AZC)) for 6 weeks. Pancreatic enzymes in the serum were not markedly influenced by administration of antifibrotic substances, and there were no differences in the ratios of dry to wet weights of the pancreas between groups with and without these drugs. After freezing, the hydroxyproline levels in the pancreas of the control group increased from 1 to 4 weeks and then decreased during the 5th and 6th weeks. All groups receiving colchicine or AZC exhibited a significant decrease in the hydroxyproline levels at 2 to 4 weeks compared with the control group (P less than 0.01). Histological examination also showed the inhibition of pancreatic fibrosis, agreeing with changes in the hydroxyproline levels in groups receiving colchicine or AZC. These results suggest that administration of antifibrotic substances, colchicine and AZC, have the possibility of inhibiting pancreatic fibrosis following acute pancreatitis.
D000818:Animals; D001383:Azetidinecarboxylic Acid / Q000627:therapeutic use*; D001385:Azetines / Q000627:therapeutic use*; D003078:Colchicine / Q000627:therapeutic use*; D005355:Fibrosis; D006909:Hydroxyproline / Q000378:metabolism; D008297:Male; D010179:Pancreas / Q000473:pathology; D010195:Pancreatitis / Q000150:complications / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains
D001385:Azetines; D001383:Azetidinecarboxylic Acid; D006909:Hydroxyproline; D003078:Colchicine